|
|
Volumn 18, Issue 6, 2001, Pages 1287-1292
|
|
Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
COMPLEMENTARY RNA;
HTR RNA;
TELOMERASE;
UNTRANSLATED RNA;
ANIMAL;
APOPTOSIS;
ARTICLE;
BAGG ALBINO MOUSE;
CELL CULTURE;
CELL SURVIVAL;
CENTRAL NERVOUS SYSTEM TUMOR;
DRUG COMBINATION;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
GENE THERAPY;
GENETICS;
GLIOMA;
HUMAN;
METABOLISM;
METHODOLOGY;
MOUSE;
NICK END LABELING;
NUDE MOUSE;
PATHOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL SURVIVAL;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
CISPLATIN;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
GENE THERAPY;
GLIOMA;
HUMANS;
IN SITU NICK-END LABELING;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
RNA, ANTISENSE;
RNA, UNTRANSLATED;
TELOMERASE;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
|
EID: 0035375098
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.18.6.1287 Document Type: Article |
|
Times cited : (39)
|
|
References (0)
|
